Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan;50(1):98-106.
doi: 10.1111/coa.14243. Epub 2024 Oct 10.

Additive Effect of Blood and Tissue Eosinophilia on Chronic Rhinosinusitis With Nasal Polyps

Affiliations

Additive Effect of Blood and Tissue Eosinophilia on Chronic Rhinosinusitis With Nasal Polyps

Peipei Yang et al. Clin Otolaryngol. 2025 Jan.

Abstract

Purpose: Chronic rhinosinusitis with nasal polyps (CRSwNP) is a highly heterogeneous disease with varied clinical features and treatment effects. This study aimed to investigate the additive effect of blood and tissue eosinophilia on patients with CRSwNP.

Methods: Based on the blood eosinophil (Beos) count and tissue eosinophil (Teos) count, we divided 144 CRSwNP patients into four groups, analysed their clinical features and histopathologic changes, and investigated their postoperative control.

Results: Patients in the Beos+Teos+ (blood eosinophil count > 0.3 × 109/L, tissue eosinophil count > 10/HPF) group had a higher incidence of allergic rhinitis (AR) and asthma. Lund-Mackay (LM) scores, hyposmia visual analogue scale (VAS) scores and Global Osteitis Scoring Scale (GOSS) scores were higher in the Beos+Teos+ group than those in the other groups. Tissue remodelling, such as connective tissue oedema and basement membrane thickening was more severe in the Beos+Teos+ group compared with other groups. There were more uncontrolled patients after surgery in Beos+Teos+, Beos+Teos- (blood eosinophil count > 0.3 × 109/L, tissue eosinophil count ≤ 10/HPF)and Beos-Teos+ (blood eosinophil count ≤ 0.3 × 109/L, tissue eosinophil count > 10/HPF)groups compared with the Beos-Teos- group.

Conclusions: Eosinophilic inflammation both in blood and tissue was accompanied by more severe clinical features and tissue remodelling. Eosinophilia in blood or tissue indicated poorer disease control after surgery.

Keywords: blood eosinophilia; chronic rhinosinusitis with nasal polyps; disease control; tissue eosinophilia; tissue remodelling.

PubMed Disclaimer

References

    1. W. Fokkens, V. J. Lund, C. Hopkins, et al., “European Position Paper on Rhinosinusitis and Nasal Polyps 2020,” Rhinology 58 (2020): 1–464.
    1. C. Bachert, B. Marple, R. J. Schlosser, et al., “Adult Chronic Rhinosinusitis,” Nature Reviews. Disease Primers 6, no. 1 (2020): 86.
    1. L. L. Shi, P. Xiong, L. Zhang, et al., “Features of Airway Remodeling in Different Types of Chinese Chronic Rhinosinusitis Are Associated With Inflammation Patterns,” Allergy 68, no. 1 (2013): 101–109.
    1. S. A. Shah, H. Ishinaga, and K. Takeuchi, “Pathogenesis of Eosinophilic Chronic Rhinosinusitis,” Journal of Inflammation (London) 13 (2016): 11.
    1. T. McHugh, K. Snidvongs, M. Xie, S. Banglawala, and D. Sommer, “High Tissue Eosinophilia as a Marker to Predict Recurrence for Eosinophilic Chronic Rhinosinusitis: A Systematic Review and Meta‐Analysis,” International Forum of Allergy & Rhinology 8, no. 12 (2018): 1421–1429.